Armotraz® (Anastrozole)

Anastrozole 1mg Tablets (10 Tab) — Aromatase inhibitor

Additional information

Composition

Anastrozole 1 mg

Manufacturer

Cipla Ltd.

Country

India

Pack size

10 tablets

Storage

Store as directed on the pack (reference label: 20°C to 25°C)

Prescription medicine

Supplied only against a valid prescription from a registered medical practitioner.

100% genuine

Sourced from authorised channels

Cold-chain delivery

Temperature-controlled packing

Pan-India delivery

Hospitals, clinics, pharmacies

Licensed distributor

Delhi drug licence holder

Product information

Armotraz® (Anastrozole) — Aromatase Inhibitor Tablets: A Sourcing Guide for Hospitals and Oncology Pharmacies

Armotraz® is a brand of anastrozole 1 mg tablets manufactured by Cipla. Anastrozole is a non-steroidal aromatase inhibitor. According to the approved US prescribing information for anastrozole (Arimidex®), it is indicated for the adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer, first-line treatment of hormone receptor-positive or hormone receptor-unknown locally advanced or metastatic breast cancer, and the treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen. The decision to prescribe anastrozole, including duration and monitoring, rests entirely with the treating physician. This page provides sourcing and procurement information for hospitals and pharmacies, not clinical or treatment guidance.

As both a trusted medicine distributor in Delhi and a licensed pharmaceutical distributor in Delhi, A.K. Pharma supplies genuine Armotraz (Anastrozole) to hospitals, oncology centres and pharmacies across India. Buyers comparing pharmaceutical distribution companies and wholesale pharmaceutical distributors can also browse our full product range and the cancer medicines category. Supply is in bulk/wholesale quantities only.


What is Armotraz (Anastrozole)?

Armotraz contains anastrozole 1 mg, a selective non-steroidal aromatase inhibitor. The prescribing information explains that the growth of many breast cancers is stimulated or maintained by estrogens, and that in postmenopausal women estrogens are mainly produced when the aromatase enzyme converts adrenal androgens into estrone and estradiol.

How it works, according to the label: By inhibiting the aromatase enzyme, anastrozole lowers serum estradiol concentrations. The label reports that it has no detectable effect on the formation of adrenal corticosteroids or aldosterone.


Indications as Listed in the Approved Label

The indications below are taken from the US prescribing information for anastrozole (reference brand Arimidex, DailyMed). Indications in India are defined by the Indian regulator and the product’s own label.

  • Adjuvant treatment of postmenopausal women with hormone receptor-positive early breast cancer
  • First-line treatment of postmenopausal women with hormone receptor-positive or hormone receptor-unknown locally advanced or metastatic breast cancer
  • Treatment of advanced breast cancer in postmenopausal women with disease progression following tamoxifen therapy

Clinical Studies and Evidence

The study below is summarised as described in the prescribing information and its publication. It is cited for information about the evidence behind the label and is not a recommendation for any patient.

  • ATAC trial (ATAC Trialists’ Group, The Lancet, 2002): a multicentre, double-blind trial that randomised 9,366 postmenopausal women with operable breast cancer to anastrozole 1 mg, tamoxifen 20 mg, or the combination for five years or until recurrence. The primary endpoint was disease-free survival. The label notes that the combination arm showed no efficacy benefit over tamoxifen at 33 months and was discontinued. Read the publication.

Available Presentation

Brand Presentation Strength Administration
Armotraz® (Cipla) Tablets, pack of 10 Anastrozole 1 mg Oral (per prescribing information)

The reference label describes a once-daily oral tablet. The dosing, duration and monitoring for any patient must be determined and followed exactly as directed by the treating physician.


Key Benefits for Procurement

  • Genuine, sealed original-pack stock from the manufacturer’s supply chain
  • Oral tablet presentation with a standard 10-tablet pack that suits hospital and pharmacy stocking
  • Batch and expiry details provided on request
  • Documentation support for hospital purchase departments
  • Companion breast cancer medicines available from the same distributor

Who Is This Page For?

This page is written for hospital pharmacists, oncology department buyers and pharmacies that stock hormone therapy for breast cancer. Anastrozole is prescribed and monitored by a qualified physician, as described in the prescribing information.


Possible Side Effects Reported in the Label

The US prescribing information for anastrozole reports adverse reactions in the ATAC trial occurring in at least 5% of patients, including asthenia, pain, back pain, headache and abdominal pain. It lists warnings for ischemic cardiovascular events in women with pre-existing ischemic heart disease, decreases in bone mineral density, increases in total cholesterol, and embryo-fetal toxicity. Hypersensitivity reactions, including anaphylaxis and angioedema, are also described. This list is not complete; the full prescribing information governs.


Precautions

  • The label contraindicates use in patients with a hypersensitivity reaction to the drug or any excipient.
  • The label notes that anastrozole may cause fetal harm and advises effective contraception.
  • The label states that tamoxifen should not be administered with anastrozole, based on clinical and pharmacokinetic results from the ATAC trial.

All use should follow the approved prescribing information and the instructions of the treating physician.


Storage and Handling

Store as directed on the pack. The reference US label states controlled room temperature, 20°C to 25°C (68°F to 77°F). Keep out of reach of children.


Manufacturer Information

Armotraz is manufactured by Cipla, an Indian pharmaceutical company. A.K. Pharma is a licensed distributor and does not manufacture the product. As one of the pharmaceutical distributors serving Indian hospitals, we supply Armotraz with pack and batch details on request. Buyers comparing a pharmaceutical wholesale distributors list or a pharma distribution company can verify our credentials on the About Us page.


Related Medicines


Frequently Asked Questions

Is Armotraz available in India?
Armotraz is an Indian brand by Cipla. A.K. Pharma supplies it to hospitals and pharmacies; contact us for current availability.

What does Armotraz contain?
Anastrozole 1 mg per tablet, supplied in a pack of 10 tablets.

Can I order a single strip?
A.K. Pharma is a distributor and supplies bulk/wholesale quantities only, not one or two pieces.

How should Armotraz be stored?
As directed on the pack. The reference US label states 20°C to 25°C.

Does A.K. Pharma advise on dosing or suitability?
No. Treatment decisions, including dosing, rest solely with the treating physician and the approved prescribing information.

How do I request a quote?
Call or WhatsApp us, or use the contact details below.


Why Order from A.K. Pharma

  • Licensed pharmaceutical distributor in Delhi with 25+ years in specialty medicines
  • Genuine, original-pack stock
  • Bulk/wholesale supply to hospitals, oncology centres and pharmacies
  • Batch and expiry details on request
  • Companion breast cancer medicines available from one distributor
  • Dedicated team for hospital procurement queries

Sources and Further Reading


Contact A.K. Pharma for Armotraz Supply

📍 E-2/257A, 2nd Floor, Shastri Nagar, New Delhi 110052
📞 011 4172 6999
📱 WhatsApp: +91 9810034827
🌐 akpharma.in


Disclaimer: This page is intended for informational and sourcing/procurement purposes only and does not constitute medical or clinical advice. A.K. Pharma is a licensed medicine distributor, not a healthcare provider, and does not provide clinical guidance. All treatment decisions, including drug selection and dosing, rest solely with the treating physician and should follow the approved prescribing information.

Hi! 👋 Looking for a medicine? I can help you find it.

Quote Request Form


Quote Request Form